Welcome to our dedicated page for 22Nd Century SEC filings (Ticker: XXII), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for 22nd Century Group, Inc. (Nasdaq: XXII) brings together the company’s official U.S. Securities and Exchange Commission disclosures, offering a detailed view of its capital structure, governance and tobacco harm reduction strategy. For a company built around reduced nicotine combustible products, these filings explain how 22nd Century funds VLN® commercialization, manages regulatory risk and structures shareholder approvals.
Through annual reports on Form 10-K and quarterly reports on Form 10-Q, investors can review narrative and financial information on the VLN® reduced nicotine cigarette platform, the company’s proprietary non-GMO low nicotine tobacco technology, and its focus on tobacco harm reduction. These reports also describe key risks related to FDA regulation, Modified Risk Tobacco Product (MRTP) status, and the proposed Tobacco Product Standard for Nicotine Yield of Cigarettes and Certain Other Combusted Tobacco Products.
Current reports on Form 8-K provide timely updates on material events, including repayment and termination of senior secured credit facilities, settlement of insurance claims, Series A convertible preferred stock terms, warrant amendments, the establishment of an at-the-market equity offering, and exclusive manufacturing agreements for Pinnacle cigarette and moist snuff brands. Proxy statements on Schedule 14A detail stockholder votes on increasing authorized shares, reverse stock split authority, equity incentive plans and other Nasdaq-related approvals.
This page also offers access to insider and capital structure information, including Forms 3, 4 and 5 for insider transactions when available, and registration statements or prospectus supplements related to equity offerings. Stock Titan’s tools layer AI-powered summaries over complex documents such as 10-Ks, 10-Qs, 8-Ks and proxy statements, helping readers quickly identify how financing arrangements, MRTP-related disclosures, and regulatory commentary may affect 22nd Century’s reduced nicotine business. Real-time updates from EDGAR ensure that new filings appear promptly, while AI highlights key terms, conversion features, reverse split proposals and other structural details that matter to XXII shareholders.
22nd Century Group (XXII) has entered into a significant Master Services Agreement with an existing customer, expanding their manufacturing partnership. The new five-year exclusive agreement represents a substantial expansion of their previous supply relationship.
Key aspects of the agreement include:
- Exclusive manufacturing rights for four existing Pinnacle cigarette brands currently in retail distribution
- Rights to manufacture up to seven new products, including three low nicotine SKUs, two natural style brands, and two moist snuff products
- Royalty payment structure to Customer for each carton manufactured and sold to distributors
This strategic agreement strengthens 22nd Century Group's position in the tobacco manufacturing sector and expands their product portfolio beyond their previous cigarette-only supply arrangement. The agreement's details will be fully disclosed in the company's upcoming Annual Report.
22nd Century Group, Inc. (Nasdaq: XXII) has filed a Form S-3 shelf registration statement covering the potential resale of up to 8,588,811 shares of common stock. The shares are issuable upon exercise of warrants that were granted in two recent private placements (October 24 2024 and April 30 2025). The warrants include an “alternate cashless exercise” feature that allows holders to receive two shares for a zero exercise price, meaning the company will not receive any cash proceeds when the warrants are exercised. 22nd Century will also receive no proceeds from subsequent sales by the selling stockholders; it is registering the shares solely to permit their resale.
The company classifies itself as a non-accelerated filer and a smaller reporting company. The filing indicates that the shares may be sold from time to time in a variety of transactions—at fixed, market, or negotiated prices—without underwriting discounts paid by the company. 22nd Century has agreed to bear the registration expenses, while the selling stockholders will cover any brokerage commissions.
Key reference data contained in the filing include: (i) 4,851,913 shares tied to October 2024 investor warrants, (ii) 300,458 shares related to placement-agent warrants from the same 2024 transaction, and (iii) 3,436,440 shares issuable from April 2025 warrants. The company’s common stock last closed at $10.12 on 18 June 2025. Investors are directed to the prospectus Risk Factors section—which highlights continued operating losses, Nasdaq compliance concerns, and competitive pressures—for a full discussion of potential hazards.
Implications for shareholders:
- The registration increases the tradable float by up to 8.6 million shares, potentially creating share-price overhang.
- Because the cashless exercise delivers shares without payment, the transaction is non-dilutive to cash but dilutive to EPS and ownership percentages.
- No capital inflow means the company’s liquidity position is unchanged by this filing.